RCUS 1M 7.4% Increase and then 77% Decline

Penjualan

Arcus Biosciences, Inc. (NYSE:RCUS)

Diupdate

NYSE:RCUS Arcus Biosciences, Inc.

Trend Analysis Beyond Technical Analysis

Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.

Komentar:

Measured move to $12.18 by Nov 2023

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.